ENVERIC BIOSCIENCES, INC. Accumulated Other Comprehensive Income
ENVERIC BIOSCIENCES, INC. (ENVB) had Accumulated Other Comprehensive Income of -$594.68 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$594.68K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$587.06K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$580.04K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$580.95K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$594.68K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$587.06K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$580.04K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$580.95K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$573.53K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$598.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$594.52K 10-K · filed 2026-03-27 | |
| 2024-09-30 | -$535.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$566.50K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$551.84K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$569.75K 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$535.62K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$546.05K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | -$534.77K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$536.73K 10-K · filed 2024-03-26 | |
| 2022-09-30 | -$640.50K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$223.11K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $57.91K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$30.80K 10-K/A · filed 2023-06-09 | |
| 2021-09-30 | -$185.31K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$178.80K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$145.54K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$181.28K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $51.77K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $39.86K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $24.51K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$11.62K 10-K · filed 2021-04-01 | $60.01K 10-K · filed 2020-03-25 |
| 2019-09-30 | $69.59K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $87.57K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $105.71K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $87.00K 10-K/A · filed 2020-08-12 | |
| 2018-09-30 | $36.08K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $34.36K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $66.67K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $36.88K 10-K · filed 2019-03-26 | |
| 2017-09-30 | -$18.51K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$4.28K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $740.00 10-Q/A · filed 2017-05-15 | |
| 2016-12-31 | -$7.43K 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$287.72K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |